o2h Discovery is a leading co-discovery partner for pre-clinical biotech & big pharma. We have built an insights-driven, multi-modality integrated discovery platform located in the UK & India. We are seeking an exceptional Senior medicinal chemist who is willing to work & co-locate both in India and the UK/USA/EU to lead FTE drug discovery projects.
What You’ll Do
Lead integrated, multi-modality drug discovery across chemistry disciplines.
Address complex synthesis challenges using advanced analytical approaches.
Apply modern discovery platforms, including ELNs, cheminformatics, and digital workflows.
Collaborate with biology, ADME/DMPK, and platform sciences for integrated delivery.
Mentor scientists to global standards of quality and scientific rigour.
Build and represent o2h Discovery partnerships with global biotech clients.
Skills we value
Medicinal & synthetic chemistry expertise with strong route design and problem-solving.
Advanced troubleshooting using digital chemistry and modern discovery platforms.
Experience across advanced modalities (ADCs, peptides, covalent inhibitors, TPD) and productivity tools (HTE, flow).
Strong scientific communication and influence in global collaborations.
Demonstrated ability to mentor, guide, and develop scientific teams.
Qualifications & Experience
Ph.D/Postdoc from a leading international university (US/UK/EU strongly preferred).
5–20 years of industrial experience in small-molecule drug discovery.
o2h group seeds new ideas in science, technology and green innovation. We work across boundaries and take a collaborative and shared approach to innovation, and therefore we co-invest, co-create and co-execute to bring these ideas to life. o2h group is organised into 6 symbiotic verticals; o2h ventures, o2h discovery, o2h therapeutics, o2h technology, o2h co-work, and o2h community.
o2h discovery is an integrated chemistry and biology services platform for executing collaborative research. o2h technology works on proprietary software projects for in-house portfolio companies.
o2h ventures is an engine for nurturing early stage life science and technology assets through seed investment.
o2h therapeutics is seeding a novel pipeline of proprietary pre-clinical IP in Immunoncology (glioblastoma, breast cancer), anti-ageing and diabetes.
o2h co-working space located in Hauxton, Cambridge, UK and o2h community covers our work with local non-profits organisations, our interests in working with social enterprise and our work in creating a community of innovators that can impact society.
o2h group is co-located in Ahmedabad, India and in Cambridge UK. Please see www.o2h.com for more details.
